These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28963995)

  • 1. Development of one paediatric and one neonatal formulary list in hospital settings.
    Haslund-Krog SS; Rolighed Christensen H; Bjerager M; Holst H
    Br J Clin Pharmacol; 2018 Feb; 84(2):349-357. PubMed ID: 28963995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the drug formulary and the purchasing process at a Moroccan university medical center.
    Lachhab Z; Serragui S; Hassar M; Cherrah Y; Errougani A; Ahid S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):415-421. PubMed ID: 29781758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study of the processes and outcomes of paediatric formulary applications in Australia.
    Sinha YK; Craig JC; Barclay PG; Miller H; Turner SC; Whitehouse JP; Brien JA
    Med J Aust; 2014 May; 200(9):541-5. PubMed ID: 24835719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of non-formulary drugs in children at a Brazilian teaching hospital: a descriptive study.
    Tramontina MY; Heineck I; Dos Santos L
    Pharm Pract (Granada); 2013 Jan; 11(1):17-23. PubMed ID: 24155845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priority setting in a hospital drug formulary: a qualitative case study and evaluation.
    Martin DK; Hollenberg D; MacRae S; Madden S; Singer P
    Health Policy; 2003 Dec; 66(3):295-303. PubMed ID: 14637013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing drug formularies for the "National Medical Holding" JSC.
    Akhmadyar NS; Khairulin BE; Amangeldy-Kyzy S; Ospanov MA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S51-2. PubMed ID: 26639709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary management.
    Scroccaro G
    Pharmacotherapy; 2000 Oct; 20(10 Pt 2):317S-321S. PubMed ID: 11034059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
    Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
    Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases.
    Bazzell B; Wagner D; Durant KM; Callahan B
    Am J Health Syst Pharm; 2020 Oct; 77(21):1763-1770. PubMed ID: 32705115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of hospital formularies.
    Rucker TD
    Pharm Weekbl Sci; 1988 Aug; 10(4):145-50. PubMed ID: 3174366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.
    Fijn R; de Jong-van den Berg LT; Brouwers JR
    Pharm World Sci; 1999 Apr; 21(2):74-9. PubMed ID: 10380234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grampian Health Board's joint drug formulary.
    Garvey G; Jappy B; Stewart D; Williams A; Duffus PR; Maitland JM; Valentine MJ; Wedderburn S; Webster J; Petrie JC
    BMJ; 1990 Oct; 301(6756):851-2. PubMed ID: 2282424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of Canadian general pediatric dosing publications.
    Dayneka N
    Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a children's Drugs and Therapeutics Committee to ensure evidence-based and cost-effective medical treatment for children.
    Holst SS; Møller CH; Vermehren C; Trolle S; Hansen B; Kirkedal AK; Christensen HR; Jacobsen T; Mathiasen R; Andersen JÞT; Gade C
    Br J Clin Pharmacol; 2024 Feb; 90(2):378-387. PubMed ID: 37879905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.
    Uppal NK; Dupuis LL; Parshuram CS
    Paediatr Drugs; 2008; 10(3):193-7. PubMed ID: 18454571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.
    Matlala M; Gous AGS; Meyer JC; Godman B
    Front Pharmacol; 2020; 11():1267. PubMed ID: 32973508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.